Disparities in the Early Adoption of Chemoimmunotherapy for Diffuse Large B-cell Lymphoma in the United States.

The article discusses a study which aims to described the clinical and demographic features of patients with Diffuse Large B-cell Lymphoma (DLBCL) who received combination of chemoimmunotherapy, assess the differences between patients with DLBCL who received chemoimmunotherapy and those who did not and examine time trends in the use of chemoimmunotherapy for patients with DLBCL. It suggests for appropriate and beneficial services to cancer patients based on scientific knowledge.